Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,767 | 412 | 71.3% |
| Consulting Fee | $2,495 | 3 | 22.9% |
| Education | $627.60 | 9 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,896 | 13 | $0 (2024) |
| Incyte Corporation | $1,299 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $1,216 | 43 | $0 (2024) |
| ABBVIE INC. | $1,170 | 85 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $734.45 | 46 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $631.73 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $580.95 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $482.73 | 22 | $0 (2024) |
| Lilly USA, LLC | $391.99 | 17 | $0 (2024) |
| Galderma Laboratories, L.P. | $372.93 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,900 | 113 | Incyte Corporation ($1,119) |
| 2023 | $3,227 | 111 | Ortho Dermatologics, a division of Bausch Health US, LLC ($1,065) |
| 2022 | $2,037 | 106 | ABBVIE INC. ($378.45) |
| 2021 | $1,726 | 94 | AbbVie Inc. ($357.73) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.31 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Education | In-kind items and services | $10.29 | General |
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.85 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Immunology | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.23 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology | ||||||
| 10/30/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.40 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Immunology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.41 | General |
| Category: Immunology | ||||||
| 10/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Immunology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 645 | 900 | $101,910 | $34,632 |
| 2022 | 14 | 664 | 1,238 | $118,570 | $39,667 |
| 2021 | 14 | 656 | 952 | $100,488 | $36,009 |
| 2020 | 4 | 57 | 68 | $10,034 | $3,183 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 147 | $16,905 | $7,252 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 107 | $19,260 | $7,103 | 36.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 118 | $20,178 | $7,011 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 130 | 168 | $17,304 | $5,260 | 30.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $6,071 | $1,941 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,536 | $1,325 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $5,140 | $1,306 | 25.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 27 | 27 | $3,105 | $992.13 | 32.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 75 | 227 | $4,086 | $890.66 | 21.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 31 | $2,325 | $869.28 | 37.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 15 | 15 | $3,000 | $681.92 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 119 | $21,420 | $8,758 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 138 | $15,870 | $6,821 | 43.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 77 | 96 | $16,416 | $6,193 | 37.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 119 | 164 | $16,892 | $4,909 | 29.1% |
| 96900 | Application of ultraviolet light to skin | Office | 2022 | 12 | 207 | $12,420 | $2,537 | 20.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $5,712 | $1,837 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,397 | $1,739 | 32.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 83 | 330 | $5,940 | $1,376 | 23.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2022 | 19 | 22 | $4,048 | $1,337 | 33.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 19 | 19 | $3,800 | $864.48 | 22.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 30 | $2,250 | $845.74 | 37.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 17 | 20 | $3,000 | $828.48 | 27.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 23 | 23 | $2,645 | $815.67 | 30.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 14 | 15 | $2,760 | $803.95 | 29.1% |
About Alex Meiser, NP-C
Alex Meiser, NP-C is a Nurse Practitioner healthcare provider based in Fairlawn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1962054585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alex Meiser, NP-C has received a total of $10,890 in payments from pharmaceutical and medical device companies, with $3,900 received in 2024. These payments were reported across 424 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,767).
As a Medicare-enrolled provider, Meiser has provided services to 2,022 Medicare beneficiaries, totaling 3,158 services with total Medicare billing of $113,490. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Fairlawn, OH
- Active Since 07/13/2019
- Last Updated 03/13/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1962054585
Products in Payments
- TREMFYA (Drug) $913.50
- Cabtreo (Drug) $772.71
- DUPIXENT (Biological) $756.88
- Sotyktu (Drug) $724.16
- SKYRIZI (Biological) $670.13
- ILUMYA (Biological) $411.92
- COSENTYX (Biological) $390.88
- TALTZ (Drug) $370.50
- RINVOQ (Biological) $332.59
- VTAMA (Drug) $284.67
- OPZELURA (Drug) $278.56
- AKLIEF (Drug) $273.62
- Bimzelx (Biological) $244.44
- STELARA (Biological) $175.01
- COSENTYX (Drug) $150.77
- ADBRY (Biological) $141.28
- Zoryve (Drug) $131.31
- REMICADE (Biological) $127.77
- Cimzia (Drug) $127.67
- HUMIRA (Biological) $117.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fairlawn
Michael Kesselring, Np, NP
Nurse Practitioner — Payments: $4,107
Mary Lesko, Cnp, CNP
Nurse Practitioner — Payments: $1,395
Lindsay Brasko, Cnp, CNP
Nurse Practitioner — Payments: $570.28
Arianna Smola, Bsn, Msn Fnp-Bc Aprn, BSN, MSN FNP-BC APRN
Nurse Practitioner — Payments: $138.28
Gina Fegatelli, Cnp, CNP
Nurse Practitioner — Payments: $55.03
Brandi Heffelfinger, Cnp, CNP
Nurse Practitioner — Payments: $29.26